Ladenburg Thalmann Financial Services’s CASI Pharmaceuticals CASI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
$6K Sell
200
-5
-2% -$162 ﹤0.01% 4686
2019
Q3
$7K Hold
205
﹤0.01% 4530
2019
Q2
$6K Hold
205
﹤0.01% 4624
2019
Q1
$6K Hold
205
﹤0.01% 4576
2018
Q4
$8K Hold
205
﹤0.01% 4383
2018
Q3
$9K Hold
205
﹤0.01% 4328
2018
Q2
$8K Hold
205
﹤0.01% 4354
2018
Q1
$8K Buy
205
+200
+4,000% +$7.47K ﹤0.01% 4354
2017
Q4
$0 Hold
5
﹤0.01% 5031
2017
Q3
$0 Hold
5
﹤0.01% 4928
2017
Q2
$0 Sell
5
-45
-90% -$478 ﹤0.01% 4872
2017
Q1
$1K Sell
50
-55
-52% -$747 ﹤0.01% 4683
2016
Q4
$1K Hold
105
﹤0.01% 4625
2016
Q3
$1K Sell
105
-90
-46% -$988 ﹤0.01% 4597
2016
Q2
$2K Hold
195
﹤0.01% 4376
2016
Q1
$2K Buy
195
+100
+105% +$969 ﹤0.01% 4356
2015
Q4
$1K Hold
95
﹤0.01% 4481
2015
Q3
$1K Hold
95
﹤0.01% 4386
2015
Q2
$2K Hold
95
﹤0.01% 4319
2015
Q1
$1K Hold
95
﹤0.01% 4396
2014
Q4
$1K Hold
95
﹤0.01% 4183
2014
Q3
$2K Buy
+95
New +$1.69K ﹤0.01% 3656
2014
Q2
Sell
-91
Closed -$2K 3887
2014
Q1
$2K Hold
91
﹤0.01% 3494
2013
Q4
$2K Hold
91
﹤0.01% 3490
2013
Q3
$2K Hold
91
﹤0.01% 3427
2013
Q2
$2K Buy
+91
New +$1.76K ﹤0.01% 3300

Other funds holding CASI

Ladenburg Thalmann Financial Services's CASI Position: Q4 2019 in Review

Ladenburg Thalmann Financial Services reduced its CASI Pharmaceuticals (CASI) stake by 2.4% in Q4 2019, selling an estimated $162 and leaving 200 shares worth $6K. The position accounts for ﹤0.01% of the portfolio, ranked #4686.

Ladenburg Thalmann Financial Services first reported a position in CASI in Q2 2013 and has held it in 26 quarters since. The position peaked at $9K in Q3 2018. 53 funds tracked by Wall St. Rank hold CASI as of Q4 2019.

  • Ladenburg Thalmann Financial Services held 200 shares of CASI Pharmaceuticals worth $6K as of Q4 2019.
  • Ladenburg Thalmann Financial Services sold 5 CASI Pharmaceuticals shares in Q4 2019, an estimated $162.
  • CASI Pharmaceuticals made up ﹤0.01% of Ladenburg Thalmann Financial Services's portfolio in Q4 2019, its #4686 holding.
  • Ladenburg Thalmann Financial Services first reported a position in CASI Pharmaceuticals in Q2 2013 and has held it in 26 quarters since.
  • Ladenburg Thalmann Financial Services's CASI Pharmaceuticals position peaked at $9K in Q3 2018.
  • 53 funds tracked by Wall St. Rank held CASI Pharmaceuticals as of Q4 2019.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q4 2019, filed 14 Feb 2020.